<DOC>
	<DOCNO>NCT02022956</DOCNO>
	<brief_summary>The purpose study evaluate PK property , tolerability , safety lorcaserin HCL ( BELVIQ ) obese adolescent subject age 12 17 year old</brief_summary>
	<brief_title>Single Dose Study Determine Safety , Tolerability , Pharmacokinetic Properties Lorcaserin Hydrochloride ( BELVIQ ) Obese Adolescents From 12 17 Years Age</brief_title>
	<detailed_description>The purpose : 1 . Assess single-dose pharmacokinetic ( PK ) parameter lorcaserin primary metabolite ( M1 M5 ) obese adolescent subject age 12-17 ( inclusive ) 2 . Assess safety tolerability single oral dose lorcaserin obese adolescent subject age 12-17 ( inclusive )</detailed_description>
	<criteria>1 . Adolescent subject age 12 17 year , inclusive screen 2. . Eligible female subject sexually active : nonpregnant nonlactating agree continue use accept method birth control least 1 month study medication administration 3 . BMI ≥ 95th percentile age gender , ≤ 44 kg/m21 4 . Considered stable health opinion Investigator . 5 . Parent guardian sign write informed consent subject willing sign assent 1 . Clinically significant new illness 1 month screening time prior randomization 2 . Significant renal hepatic disease 3 . Secondary ( chromosomal , endocrine , metabolic ) cause obesity 4 . Use medication hormonal contraceptive acetaminophen 5 . Use drug serotonergic activity within 1 month screen 6 . Recent treatment overthecounter weight loss product appetite suppressant , within 3 month screening time prior randomization prescription weight loss drug lipid dissolve injection ongoing psychotherapy weight loss outside trial 7 . Recent history alcohol , tobacco , recreational drug/solvent use 8 . Any history major depression , anxiety , bipolar disorder , schizophrenia , Axis II psychiatric disease require treatment prescription medication within six month prior screen</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>